{"id":8,"date":"2022-06-24T18:30:17","date_gmt":"2022-06-24T18:30:17","guid":{"rendered":"https:\/\/www.msd.com\/india\/?page_id=8"},"modified":"2026-04-27T08:45:34","modified_gmt":"2026-04-27T08:45:34","slug":"about-us","status":"publish","type":"page","link":"https:\/\/www.msd.com\/india\/","title":{"rendered":"About Us"},"content":{"rendered":"\n
\n
\n
\n
\n \n\t\n\n\n\n\t\"\"\n<\/picture> <\/div>\n
\n <\/div>\n <\/div>\n\n
\n \n

IMPROVING HEALTH IMPROVING LIVES<\/h1>\n \n \n <\/div>\n <\/div>\n\n \n<\/div>\n\n\n\n

About Us<\/strong><\/span><\/h2>\n\n\n\n

MSD India Board of Directors<\/h2>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Chand Berry<\/strong><\/p>\n\n\n\n

Chief Financial Officer<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Disha Thakkar<\/strong><\/p>\n\n\n\n

General Counsel – Legal & Compliance<\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n

MSD India Leadership Team<\/h2>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Brecht Vanneste<\/strong><\/strong><\/strong><\/p>\n\n\n\n


Managing Director<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Bhargavi Kakunuri<\/strong><\/p>\n\n\n\n


Executive Director \u2013 Human Resources<\/p>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Chand Berry<\/strong><\/p>\n\n\n\n


Chief Financial Officer<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Saurav Patyal<\/strong><\/strong><\/p>\n\n\n\n


Director –
Oncology<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Dr. Monisha Sharma<\/strong><\/p>\n\n\n\n

Clinical Research Director –
India, Vietnam, Philippines and Indonesia<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n\n\n\n

Dr. Mamta Singh<\/strong><\/p>\n\n\n\n


Sr. Director \u2013 Regulatory Affairs<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

Sachin Sable<\/strong><\/p>\n\n\n\n


Supply Chain Execution Lead \u2013 South Asia (India, ANZ, SGMY & Indonesia)<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

Alok Kumar Sengupta<\/strong><\/p>\n\n\n\n

Director –
Business Development<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Manjunath Moodbidri<\/strong><\/strong><\/p>\n\n\n\n

Business Technology Partner \u2013 India, Singapore, Malaysia, Vietnam and Indonesia<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Ravindra Sangam<\/strong><\/p>\n\n\n\n


Director \u2013
Strategic Alliances, Asia Pacific<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure><\/div>\n\n\n

Anushree<\/strong> Lakshminarayanan<\/strong><\/p>\n\n\n\n

Director –
Strategic Access, Policy & Communications (SAPC)<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Dr. Rohit Ghatule<\/strong><\/strong><\/p>\n\n\n\n


Director – Cardiovascular (PAH)<\/p>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Disha Thakkar<\/strong><\/strong><\/p>\n\n\n\n


General Counsel – Legal & Compliance<\/p>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

\n

<\/p>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

\n

<\/p>\n<\/div>\n<\/div>\n\n\n\n

Contact us<\/strong><\/span><\/h2>\n\n\n\n

MSD in India<\/h3>\n\n\n\n

Registered Office:<\/strong>
1544, Level 15, Eros Corporate Towers, Nehru Place, New Delhi- 110019<\/p>\n\n\n\n

Communication Office:<\/strong>
WeWork Enam Sambhava, 7th, 8th and 9th floor, C-20, G Block, Bandra Kurla Complex, Bandra East, Mumbai \u2013 400051
Tel: +91 22 67898888 I Fax: +91 22 67898889
Toll free number: 18001032642
For Media & Communications:<\/strong> media_india@msd.com<\/a><\/p>\n\n\n\n

English :<\/strong><\/p>\n\n\n\n

 To report an adverse experience related to MSD product, email us at dpoc_india@msd.com<\/a><\/p>\n\n\n\n

Hindi:<\/strong><\/p>\n\n\n\n

\u092f\u0926\u093f \u0906\u092a MSD \u0909\u0924\u094d\u092a\u093e\u0926 \u0938\u0947 \u0938\u0902\u092c\u0902\u0927\u093f\u0924 \u0915\u093f\u0938\u0940 \u092a\u094d\u0930\u0924\u093f\u0915\u0942\u0932 \u0905\u0928\u0941\u092d\u0935 \u0915\u094b \u0930\u093f\u092a\u094b\u0930\u094d\u091f \u0915\u0930\u0928\u093e \u091a\u093e\u0939\u0924\u0947 \u0939\u0948\u0902- \u092f\u0939\u093e\u0902 \u0915\u094d\u0932\u093f\u0915 \u0915\u0930\u0947\u0902<\/a><\/p>\n\n\n\n

Bengali<\/strong><\/p>\n\n\n\n

\u0986\u09aa\u09a8\u09bf \u09af\u09a6\u09bf \u0995\u09cb\u09a8\u0993 \u098f\u09ae\u098f\u09b8\u09a1\u09bf \u09aa\u09a3\u09cd\u09af \u09b8\u09ae\u09cd\u09aa\u09b0\u09cd\u0995\u09c7 \u098f\u0995\u099f\u09bf \u09a8\u09c7\u09a4\u09bf\u09ac\u09be\u099a\u0995 \u0985\u09ad\u09bf\u099c\u09cd\u099e\u09a4\u09be \u09b0\u09bf\u09aa\u09cb\u09b0\u09cd\u099f \u0995\u09b0\u09a4\u09c7 \u099a\u09be\u09a8 \u09a4\u09ac\u09c7 \u098f\u0996\u09be\u09a8\u09c7 \u0995\u09cd\u09b2\u09bf\u0995 \u0995\u09b0\u09c1\u09a8<\/a><\/p>\n\n\n\n

Tamil<\/strong><\/p>\n\n\n\n

\u0ba8\u0bc0\u0b99\u0bcd\u0b95\u0bb3\u0bcd, \u0b92\u0bb0\u0bc1 MSD \u0ba4\u0baf\u0bbe\u0bb0\u0bbf\u0baa\u0bcd\u0baa\u0bc1 \u0b95\u0bc1\u0bb1\u0bbf\u0ba4\u0bcd\u0ba4 \u0bae\u0bcb\u0b9a\u0bae\u0bbe\u0ba9 \u0b85\u0ba9\u0bc1\u0baa\u0bb5\u0ba4\u0bcd\u0ba4\u0bc8 \u0baa\u0bc1\u0b95\u0bbe\u0bb0\u0bcd \u0b9a\u0bc6\u0baf\u0bcd\u0baf \u0bb5\u0bc7\u0ba3\u0bcd\u0b9f\u0bc1\u0bae\u0bc6\u0ba9\u0bbf\u0bb2\u0bcd – \u0b87\u0b99\u0bcd\u0b95\u0bc1 \u0b95\u0bbf\u0bb3\u0bbf\u0b95\u0bcd \u0b9a\u0bc6\u0baf\u0bcd\u0baf\u0bb5\u0bc1\u0bae\u0bcd.<\/a><\/p>\n\n\n\n

Marathi<\/strong><\/p>\n\n\n\n

\u090f\u092e\u090f\u0938\u0921\u0940 \u0909\u0924\u094d\u200d\u200d\u200d\u200d\u200d\u200d\u200d\u092a\u093e\u0926\u0928\u093e\u0936\u0940 \u0938\u0902\u092c\u0902\u0927\u093f\u0924 \u0915\u094b\u0923\u0924\u093e\u0939\u0940 \u092a\u094d\u0930\u0924\u093f\u0915\u0942\u0932 \u0905\u0928\u0941\u092d\u0935 \u0924\u0941\u092e\u094d\u200d\u0939\u093e\u0932\u093e \u0938\u093e\u0902\u0917\u093e\u092f\u091a\u093e \u0905\u0938\u0947\u0932 \u0924\u0930 – \u092f\u0947\u0925\u0947 \u0915\u094d\u0932\u093f\u0915 \u0915\u0930\u093e<\/a><\/p>\n\n\n\n

<\/p>\n\n\n\tFor healthcare professionals<\/a>\n\n\n\n\n

\n
\n
\n
\n

Disclaimer:<\/h3>\n <\/header>\n
\n

By clicking on the following link that leads me to the drug-specific SMPC\/PI, I understand the following:<\/p>\n

    \n
  1. The information contained in this link is for the sole purpose of use and knowledge of RMPs only and intended to guide such RMPs in respect of matters relating to (a) therapeutic indication of the respective drug (b) its administration (c) its dosage\u00a0 (d) its side-effects and (e) the precautions to be observed in the treatment with the drugs<\/li>\n
  2. These SMPC\/PI are drug-specific technical documents that are part of every medicine’s marketing authorization. MSD has made them available on this website on the instructions of the relevant regulatory authorities, and nothing provided therein should be construed as medical advice.<\/li>\n
  3. Patients and their relatives should not access the information contained in this link and they are advised to consult their treating physicians.<\/li>\n<\/ol>\n <\/div>\n